Results 281 to 290 of about 34,072 (291)
Some of the next articles are maybe not open access.

Choroidal Neovascularization and Coincident Perforating Scleral Vessels in Pathologic Myopia

European Journal of Ophthalmology, 2017
Purpose To describe the coincidence of perforating scleral vessels and choroidal neovascularization (CNV) in pathologic myopia. Methods Medical records and multimodal imaging were reviewed from patients with CNV secondary to pathologic myopia who presented to the Medical Retina and Imaging Unit of San Raffaele Hospital in Milan between October 2015 and
Giuffrè, Chiara   +5 more
openaire   +3 more sources

NAVIGATED LASER (NAVILAS) THERAPY FOR CHOROIDAL NEOVASCULAR AND HYPERPERMEABILITY PATHOLOGIES

RETINAL Cases & Brief Reports, 2015
To report the utility of navigated laser (NAVILAS) in the treatment of leaking areas in central serous chorioretinopathy and a feeder vessel in choroidal neovascular membrane.Two patients with choroidal lesions were treated with NAVILAS. The first patient had central serous chorioretinopathy with visible leaking angiographic spots, and the second had ...
Alshahrani, Saeed T., Ghazi, Nicola G.
openaire   +4 more sources

Transpupillary Thermotherapy of Subfoveal Choroidal Neovascularization Secondary to Pathologic Myopia

Ophthalmic Surgery, Lasers and Imaging Retina, 2010
BACKGROUND AND OBJECTIVE: To assess the safety and effectiveness of transpupillary thermotherapy treatment of subfoveal choroidal neovascular membrane secondary to pathologic myopia. PATIENTS AND METHODS: Seventy-four patients (74 eyes) with pathologic myopia underwent ...
Ashraf S Shaarawi, Khaled S Nabawi
openaire   +3 more sources

Antivascular Endothelial Growth Factor for Choroidal Neovascularization in Pathologic Myopia

2010
Choroidal neovascularization (CNV) is the most common vision-threatening macular complication in pathologic myopia (PM) being detectable in 4-11% of the affected eyes. Treatment of PM-related CNV is still controversial. Intravitreal injections of antivascular endothelial growth factor molecules are able to inhibit the vascular endothelial growth factor
Battaglia Parodi M   +2 more
openaire   +3 more sources

Intravitreal bevacizumab for the treatment of choroidal neovascularization associated with pathological myopia

Canadian Journal of Ophthalmology, 2008
The recent discovery of vascular endothelial growth factor and its role in the pathogenesis of ocular neovascularization has led to the development of new pharmacological agents that could block its action. This study was carried out to investigate the effect of intravitreal injections of bevacizumab on choroidal neovascularization (CNV) associated ...
Marc-André Rhéaume, Mikael Sebag
openaire   +3 more sources

PATHOLOGY BEYOND NEOVASCULARIZATION

Retina, 2009
Control of choroid neovascularization may be important but insufficient to preserve long-term vision threatened by age-related macular degeneration. A retrospective analysis of patients who were early participants in anti-vascular endothelial growth factor studies, other pathologic processes, particularly fibrosis and atrophy, have participated in ...
openaire   +3 more sources

Choroidal Neovascularization in Pathologic Myopia

American Journal of Ophthalmology, 2010
Vivek Pravin Dave, Raja Narayanan
openaire   +2 more sources

Growth Factors and the Retina: Normal Vascularization and Pathologic Neovascularization

1993
Growth of blood vessels within the human retina is normally completed at birth, and in other mammalian species that have been studied, including dogs, cats, mice, and rats, retinal vascularization stops within a few weeks after birth.*1 Studies of the retinas of normal adult mice and rats, using [3H]-thymidine autoradiography, have shown minimal ...
Robert N. Frank, Laura B. Sotolongo
openaire   +2 more sources

TREATMENT OF CHOROIDAL NEOVASCULARIZATION IN PATHOLOGIC MYOPIA WITH INTRAVITREAL BEVACIZUMAB

Retina, 2006
Ketan Laud   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy